Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, CVS HEALTH Corp reported revenue of $402.07B, up 7.8% year over year. Operating margin was 1.2% and net margin 0.4%, on a free-cash-flow margin of 1.9% with capital expenditure at 0.7% of revenue. Every figure is computed directly from CVS's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $402.07B | 1.2% | 0.4% |
| FY2024 | $372.81B | 2.3% | 1.2% |
| FY2023 | $357.78B | 3.8% | 2.3% |
| FY2022 | $322.47B | 2.5% | 1.3% |
| FY2021 | $292.11B | 4.6% | 2.7% |
How does CVS compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAP · ACI · AEO · AIXN · AKA · AMZN
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.